The global Telmisartan market is expected to grow in upcoming years. Factors driving the growth of market are increasing prevalence of high blood pressure, increase in incidences of chronic diseases such as diabetes, growth in geriatric population and others. On the other hand rise on approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets is expected to offer growth opportunities in telmisartan market.
Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.
The global Telmisartan markets is segmented on the basis of indication, composition and distribution channel. Based on indication, the market is segmented as hypertension, cardiac arrest and stroke. Based on composition the Telmisartan market is segmented into single and combinational. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
1. Mylan N.V.
2. Hikma Pharmaceuticals PLC
3. Exelan Pharmaceuticals, Inc.
4. Macleods Pharmaceuticals Ltd.
5. Zydus Pharmaceuticals, Inc.
6. Torrent Pharmaceuticals Ltd.
7. Jubilant Cadista.
8. Aurobindo Pharma.
9. Solco Healthcare
10. Sandoz International GmbH
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Telmisartan market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Telmisartan market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Telmisartan market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Telmisartan market in these regions.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.